ELEVANCE HEALTH, INC. (ELV) Free cash flow 2016–2025
ELEVANCE HEALTH, INC. (ELV) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$3.2BFY2025 · since FY2016: $2.7B → $3.2B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.2B | -30.3% |
| FY2024 | $4.6B | -32.7% |
| FY2023 | $6.8B | -6.7% |
| FY2022 | $7.2B | -0.4% |
| FY2021 | $7.3B | -24.7% |
| FY2020 | $9.7B | +94.0% |
| FY2019 | $5.0B | +90.3% |
| FY2018 | $2.6B | -22.8% |
| FY2017 | $3.4B | +26.4% |
| FY2016 | $2.7B | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice